The American Diabetes Association (ADA), the world’s leading academic organization on diabetes, has released its latest medical standards for diabetes care in the January 2017 issue of “diabetescare. The ADA’s Standards of Medical Care for Diabetes, known as the “Standards of Care,” are designed to provide clinicians, patients, researchers, and other interested individuals with tools for diabetes care, general treatment goals, and assessing the quality of care. The Standards of Care are designed to provide clinicians, patients, researchers, and other interested individuals with a tool for diagnosing and treating diabetes, general treatment goals, and assessing quality of care. A total of 14 chapters discuss the classification and diagnosis of diabetes; lifestyle management; diabetes prevention; and management of obese patients with type 2 diabetes. The emphasis is on the importance of lifestyle management in the development and improvement of diabetes, the addition of a new consensus on the staging/staging of type 1 diabetes, and the emphasis on a comprehensive patient-centered medical evaluation system. The section on the management of obese patients with type 2 diabetes contains many changes and adds new clinical evidence. The January 2017 issue of “diabetes care” demonstrates that gastrointestinal anatomical rearrangements and alterations in some metabolic processes directly affect glucose homeostasis, so gastrointestinal interventions are recommended as a treatment modality for type 2 diabetes and, in keeping with the ADA tissue description and to reinforce the role of surgery in the treatment of type 2 diabetes, bariatric surgery is now called metabolic surgery. Surgery is now referred to as metabolic surgery. The selection criteria for surgical patients is BMI, and the BMI criteria for metabolic surgery has been changed from 2016 to a BMI greater than or equal to 30 kg/m2 for adults or patients with type 2 diabetes (especially those with poor lifestyle interventions or medication control) to be considered for surgical treatment and is recommended for facilities with a multidisciplinary model and a large institutions. Both the ’16 and ’17 standards emphasize that the threshold for surgical treatment of diabetic patients in Asian populations can be reduced to 27.5 kg/m2. The standards emphasize that continued improvements in minimally invasive surgery (laparoscopic surgery), enhanced training, and multidisciplinary team involvement over the past two decades have led to significant improvements in the safety of metabolic surgery and a dramatic decrease in complication rates for laparoscopic surgery. dramatically decreased. Empirical data suggest that surgical surgeon proficiency is an important determinant of mortality, complications, reoperations, and readmissions. Therefore, it is particularly important that patients choose a formal institution and a skilled surgeon. The standard of care also recommends the addition of several aspects of postoperative improvement of long-term lifestyle, nutritional status and micronutrient management, and comprehensive mental health assessment. The frequency of long-term nutritional and micronutrient deficiencies and related complications depends on the type of procedure and requires lifelong vitamin/nutritional supplementation. Diabetic patients undergoing metabolic surgery also have the potential to increase the incidence of depression and other psychiatric disorders. Therefore, for surgical candidates with severe depression, suicidal ideation, or other mental health conditions, the standard of care recommends that they should first be evaluated by a mental health professional with expertise in obesity management before surgery is considered. Individuals with preoperative psychopathology should be evaluated periodically after metabolic surgery to optimize mental health management and to ensure that psychiatric symptoms do not interfere with the weight loss process and lifestyle changes. Thus, it is clear that metabolic surgery has become an important component of diabetes treatment, a fact confirmed by a large body of clinical evidence that has changed the way diabetes was understood in the past and fulfilled the expectations of diabetics for an improved quality of life.